Effect of baseline levels on response of high-density lipoprotein cholesterol to hypolipidemic treatment.
The response of high-density lipoprotein cholesterol to hypolipidemic monotherapy with diet, statins, fibrates, or nicotinic acid was investigated prospectively in 801 patients with dyslipidemia. We hypothesized that the behavior of high-density lipoprotein cholesterol after treatment would depend on its baseline levels and the therapy used.
Kolovou
Genovefa D
GD
First Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece. g_kolovou@yahoo.co.uk
Daskalova
Deliana C
DC
Petropoulos
Ilias I
II
Anagnostopoulou
Katherine K
KK
Bilianou
Helen I
HI
Pilatis
Nektarios D
ND
Pavlidis
Antonis N
AN
Cokkinos
Dennis V
DV
D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy* / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D009525:Niacin